Yves Tumor(USA)

Thu 13 Jun 2024

Date / Time

Doors 7:30PM
18+

Info

General Admission
Standing
18+


Price

From $79.90

A multi-hyphenate vocalist, producer, instrumentalist, model, Yves Tumor wields enigma and dissonance in the creation of a boundaryless practice. Their discography is wickedly dense, transgressive in delivery and bold in intent, resulting in some of the world’s most forward-thinking contemporary music.

As a 21st century rockstar unburdened by the lineage of the genre, Yves Tumor’s Praise A Lord Who Chews But Which Does Not Consume; (Or Simply, Hot Between Worlds) is strikingly modern, eclectic art rock bathed in electronic intricacies and an R&B sentiment. It’s an adventurous record circling desire and spirituality, cementing Yves Tumor as creatively postmodern and a musical impressionist. Praise A Lord… follows 2020’s fluid and ethereal, almost ambient, Heaven To A Tortured Mind, featuring tracks like ‘Kerosene!’ that are likely to resonate for the years to come. Their 2018 Warp Records debut, Safe in the Hands of Love, dwells deeper into noise and sound collage, an anxiously dark but resonant record that secured Yves in the underground canon.

Praised by The New Yorker as “unmissable”, Yves Tumor’s dynamic live performances have been felt across the globe on stages from Pitchfork to Portola to Coachella. Embodying a controlled chaos, the essence of punk emanates from the band’s presentation of their complex and emotive work. Don’t miss your chance to witness this transcendent performance live as part of Open Season.

“The art-rock auteur’s latest album is a glistening, richly detailed world that feels like a culmination of their ever-escalating talent and ambition.” - PITCHFORK

This event is presented as part of Open Season - a curated program of music and art running from May to July 2024. Open Season has been supported by the Queensland Government through Arts Queensland’s QASP program, the Strategic Partnerships Fund, and through Live Music Australia – an Australian Government initiative.